Picture of CNS Lymphoma Market: By Prognosis Type; By Diagnosis Type; By Types of Treatments; By Geography - Analysis & Forecast 2016 - 2021

CNS Lymphoma Market: By Prognosis Type; By Diagnosis Type; By Types of Treatments; By Geography - Analysis & Forecast 2016 - 2021

January 2017


Central Nervous System Lymphoma or microglioma is a disease in which cancer cells are formed in the lymph tissue of brain or spinal cord. This is observed primarily in the patients with very weak immune systems, patients suffering from immonosuppression and AIDS patients. Moreover, this disorder may affect eyes as well called as ocular lymphoma. Patients recently having kidney or other organ transplant are also at a high risk of having CNS lymphoma due to their low count of T - Cells or low level of immunity. The major symptoms of this disease majorly depend on the area affected. However, the major symptoms include headaches, memory problem, drowsiness, seizures, nausea, vomiting, personality changes, throat infection, body weakness and sometimes even hearing loss and double vision. This disease may occur in all age groups; however, mostly noticed in 50+ age group.

There are several diagnosis methods to detect CNS lymphoma; however, treatments are subjected to several clinical trials. The report covers the major diagnosis methods including lumber puncture, pathological analysis of Cerebro - Spinal Fluid scan, stereostatic biopsy, and complete blood count. Among all these, MRI scan is most widely used diagnosis method and accounts for larger percent share in the diagnosis market of CNS lymphoma. At later stage of the disease, brain biopsy, tissue biopsy, and spinal tap are the most important tests to make a definite diagnosis. Diagnosis of CNS lymphoma at early stage is difficult and can often be delayed by doctors as well as patients. 

CNS Lymphoma Market

The report highlights the prime factors impacting the growth of CNS lymphoma detection and treatment market with detailed analysis on drivers, restraints, and opportunities in the market. The major causes of the disease, its prognosis, and diagnosis are deeply analyzes and their granular level analysis is provided in the report. The report covers various treatments used for nowadays for treating CNS lymphoma. Some of these include radiation therapy, chemotherapy, high dose chemotherapy with stem cell transplant, and targeted therapy. Radiation therapy is considered most successful amongst all; however, is associated with several other complications due to repetitive radiation exposure. Chemotherapy involves usage of high dosage of drugs which may result in to other several side effects. Previously, there were very poor chances of life expectancy for a person suffering from CNS lymphoma; however, due to high technological advantages and types of available treatments these days, the life expectancy is prolonged and patients have opportunity of recovery.

The report offers in depth regional analysis of CNS lymphoma treatment and diagnosis market. The major regions covered in the report include North America, Europe, Asia - Pacific, and Latin America. The geographies with high market revenue are analyzed and the developments are exhaustively tracked for these regions. Among all the regions, Europe is estimated to have high investments in research & development of the treatments and drugs for CNS lymphoma. There is lacks disease awareness among the people in most of the countries in Asia - Pacific region but is expected to have high potential growth for the diagnosis and treatment of CNS lymphoma in next 5 years.

The report gives detailed insights on the competitiveness of the market. The report tracks the key business strategies and developments adopted by the key vendors in this market. Market share analysis of these vendors is also provided under the market entropy section. 

Some of the major research centers for the CNS lymphoma include:
Brain & spine Foundation
Royal National Institute for Blind 
Carers UK
Macmillan Cancer Support